- Home
- RGNX vs VINP Comparison
RGNX vs VINP Comparison
Compare RGNX & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- VINP
- Stock Information
- Founded
- RGNX 2008
- VINP 2009
- Country
- RGNX United States
- VINP Brazil
- Employees
- RGNX N/A
- VINP N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- VINP Investment Managers
- Sector
- RGNX Health Care
- VINP Finance
- Exchange
- RGNX Nasdaq
- VINP Nasdaq
- Market Cap
- RGNX 661.2M
- VINP 714.7M
- IPO Year
- RGNX 2015
- VINP 2021
- Fundamental
- Price
- RGNX $11.86
- VINP $11.88
- Analyst Decision
- RGNX Strong Buy
- VINP Strong Buy
- Analyst Count
- RGNX 7
- VINP 3
- Target Price
- RGNX $30.29
- VINP $13.33
- AVG Volume (30 Days)
- RGNX 537.9K
- VINP 60.0K
- Earning Date
- RGNX 11-06-2025
- VINP 11-13-2025
- Dividend Yield
- RGNX N/A
- VINP 5.05%
- EPS Growth
- RGNX N/A
- VINP N/A
- EPS
- RGNX N/A
- VINP 0.50
- Revenue
- RGNX $161,318,000.00
- VINP $180,689,571.00
- Revenue This Year
- RGNX $198.02
- VINP $67.78
- Revenue Next Year
- RGNX $2.67
- VINP $14.48
- P/E Ratio
- RGNX N/A
- VINP $23.66
- Revenue Growth
- RGNX 91.30
- VINP 100.47
- 52 Week Low
- RGNX $5.04
- VINP $8.66
- 52 Week High
- RGNX $13.93
- VINP $12.49
- Technical
- Relative Strength Index (RSI)
- RGNX 53.04
- VINP 56.34
- Support Level
- RGNX $10.70
- VINP $11.84
- Resistance Level
- RGNX $12.05
- VINP $12.13
- Average True Range (ATR)
- RGNX 0.73
- VINP 0.33
- MACD
- RGNX -0.10
- VINP -0.05
- Stochastic Oscillator
- RGNX 79.32
- VINP 39.64
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.